Belief is your safe passage—the door through which all healing resides. Why? Because your perception is your reality.
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin, the first of its kind in 20 years.
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...